Torrent Pharma Q3 profit jumps over four fold to Rs 246 crore
Torrent Pharma had posted a net profit of Rs 58 crore in the corresponding period of 2017-18, the company said in a BSE filing.
Ahmedabad: Drug firm Torrent Pharmaceuticals on Wednesday reported an over four-fold jump in consolidated net profit to Rs 246 crore for the December 2018 quarter.
It had posted a net profit of Rs 58 crore in the corresponding period of 2017-18, the company said in a BSE filing.
Consolidated revenue from operations stood at Rs 2,051 crore for the quarter, against Rs 1,463 crore a year ago.
Read Also: Torrent Pharma issues a voluntary nationwide recall of Losartan Potassium tablets: USFDA
In a separate filing, the company said its board has approved an interim dividend of Rs 13 per equity share.
The company said its board has recommended to members to obtain enabling approval for issuance of equity shares including convertible bonds/debentures through a qualified institutional placement and/or depository receipts or any other modes for an amount not exceeding Rs 5,000 crore through postal ballot.
Read Also: Torrent Pharma Q2 net profit dips 12 percent to Rs 179 crore
Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd